TechnoPhage SA-Product Pipeline Review-2016

TechnoPhage SA-Product Pipeline Review-2016

  • Products Id :- GMDHC08068CDB
  • |
  • Pages: 30
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

TechnoPhage SA-Product Pipeline Review-2016


Global Markets Direct's, 'TechnoPhage SA-Product Pipeline Review-2016', provides an overview of the TechnoPhage SA's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by TechnoPhage SA, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


The report provides a snapshot of the pipeline therapeutic landscape of TechnoPhage SA

The report provides overview of TechnoPhage SA including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses TechnoPhage SA's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features TechnoPhage SA's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

Evaluate TechnoPhage SA's strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for TechnoPhage SA

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding TechnoPhage SA's pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

TechnoPhage SA Snapshot 5

TechnoPhage SA Overview 5

Key Information 5

Key Facts 5

TechnoPhage SA-Research and Development Overview 6

Key Therapeutic Areas 6

TechnoPhage SA-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

TechnoPhage SA-Pipeline Products Glance 10

TechnoPhage SA-Early Stage Pipeline Products 10

IND/CTA Filed Products/Combination Treatment Modalities 10

Preclinical Products/Combination Treatment Modalities 11

Discovery Products/Combination Treatment Modalities 12

TechnoPhage SA-Drug Profiles 13

TA-101 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

TP-102 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

TZ-113 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

TZ-121 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

TA-111 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

TA-131 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

TP-107 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

TP-122 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

TP-132 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

TZ-151 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

TechnoPhage SA-Pipeline Analysis 24

TechnoPhage SA-Pipeline Products by Target 24

TechnoPhage SA-Pipeline Products by Molecule Type 25

TechnoPhage SA-Pipeline Products by Mechanism of Action 26

TechnoPhage SA-Dormant Projects 27

TechnoPhage SA-Locations And Subsidiaries 28

Head Office 28

Appendix 29

Methodology 29

Coverage 29

Secondary Research 29

Primary Research 29

Expert Panel Validation 29

Contact Us 29

Disclaimer 30

List of Figures

TechnoPhage SA-Pipeline by Top 10 Indication, 2016 7

TechnoPhage SA-Pipeline by Stage of Development, 2016 8

TechnoPhage SA-Monotherapy Products in Pipeline, 2016 9

TechnoPhage SA-Pipeline by Target, 2016 24

TechnoPhage SA-Pipeline by Molecule Type, 2016 25

TechnoPhage SA-Pipeline Products by Mechanism of Action, 2016 26

List of Tables

TechnoPhage SA, Key Information 5

TechnoPhage SA, Key Facts 5

TechnoPhage SA-Pipeline by Indication, 2016 7

TechnoPhage SA-Pipeline by Stage of Development, 2016 8

TechnoPhage SA-Monotherapy Products in Pipeline, 2016 9

TechnoPhage SA-IND/CTA Filed, 2016 10

TechnoPhage SA-Preclinical, 2016 11

TechnoPhage SA-Discovery, 2016 12

TechnoPhage SA-Pipeline by Target, 2016 24

TechnoPhage SA-Pipeline by Molecule Type, 2016 25

TechnoPhage SA-Pipeline Products by Mechanism of Action, 2016 26

TechnoPhage SA-Dormant Developmental Projects,2016 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of TechnoPhage SA; TechnoPhage SA-Key Therapeutics; TechnoPhage SA-Pipeline Overview and Promising Molecules; TechnoPhage SA-News; TechnoPhage SA-Latest Updates; TechnoPhage SA-Pipeline; TechnoPhage SA-Discontinued/Dormant Projects

select a license
Single User License
USD 1500 INR 110475
Site License
USD 3000 INR 220950
Corporate User License
USD 4500 INR 331425



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]